[go: up one dir, main page]

DE60110342T8 - Alpha-Interferon enthaltende Hautpflegemittel - Google Patents

Alpha-Interferon enthaltende Hautpflegemittel Download PDF

Info

Publication number
DE60110342T8
DE60110342T8 DE60110342T DE60110342T DE60110342T8 DE 60110342 T8 DE60110342 T8 DE 60110342T8 DE 60110342 T DE60110342 T DE 60110342T DE 60110342 T DE60110342 T DE 60110342T DE 60110342 T8 DE60110342 T8 DE 60110342T8
Authority
DE
Germany
Prior art keywords
skin care
interferon
alpha
care products
containing skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE60110342T
Other languages
English (en)
Other versions
DE60110342T2 (de
DE60110342D1 (de
Inventor
Jan San Jose Marini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAN MARINI SKIN RESEARCH Inc SAN JOSE
Marini Jan Skin Research Inc
Jan Marini Skin Res Inc
Original Assignee
JAN MARINI SKIN RESEARCH Inc SAN JOSE
Marini Jan Skin Research Inc
Jan Marini Skin Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAN MARINI SKIN RESEARCH Inc SAN JOSE, Marini Jan Skin Research Inc, Jan Marini Skin Res Inc filed Critical JAN MARINI SKIN RESEARCH Inc SAN JOSE
Application granted granted Critical
Publication of DE60110342D1 publication Critical patent/DE60110342D1/de
Publication of DE60110342T2 publication Critical patent/DE60110342T2/de
Publication of DE60110342T8 publication Critical patent/DE60110342T8/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60110342T 2000-11-03 2001-10-18 Alpha-Interferon enthaltende Hautpflegemittel Active DE60110342T8 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US705319 2000-11-03
US09/705,319 US6328987B1 (en) 2000-11-03 2000-11-03 Cosmetic skin care compositions containing alpha interferon

Publications (3)

Publication Number Publication Date
DE60110342D1 DE60110342D1 (de) 2005-06-02
DE60110342T2 DE60110342T2 (de) 2006-01-26
DE60110342T8 true DE60110342T8 (de) 2006-08-24

Family

ID=24832930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110342T Active DE60110342T8 (de) 2000-11-03 2001-10-18 Alpha-Interferon enthaltende Hautpflegemittel

Country Status (4)

Country Link
US (1) US6328987B1 (de)
EP (1) EP1203579B1 (de)
AT (1) ATE293953T1 (de)
DE (1) DE60110342T8 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462791A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 피부의 색소 과다 침착의 치료방법
US6821524B2 (en) 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US7014842B2 (en) * 2003-05-29 2006-03-21 Playtex Products, Inc. Sunscreen composition
WO2004105741A1 (en) * 2003-05-30 2004-12-09 Gianfranco De Paoli Ambrosi Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema
US20050226827A1 (en) * 2004-04-09 2005-10-13 Thienna Ho Skin lightening composition
EP1765280A1 (de) * 2004-06-28 2007-03-28 Procyte Corporation Verfahren und zusammensetzungen zur prävention und behandlung von hauthyperpigmentierung
US20060040002A1 (en) * 2004-08-17 2006-02-23 Boitano Suzanne M Anti-itch composition
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US20060293227A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Cosmetic compositions and methods using transforming growth factor-beta mimics
US20060293228A1 (en) * 2005-06-24 2006-12-28 Bhatnagar Rajendra S Therapeutic compositions and methods using transforming growth factor-beta mimics
US8298548B2 (en) 2007-07-18 2012-10-30 Solazyme, Inc. Compositions for improving the health and appearance of skin
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
US8277849B2 (en) 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
US20070166266A1 (en) * 2006-01-19 2007-07-19 Solazyme, Inc. Methods and compositions for improving the health and appearance of skin
US8435547B2 (en) * 2006-08-30 2013-05-07 John P. Blass Cream for stimulating mitochondrial activity in the skin
US8927522B2 (en) 2008-10-14 2015-01-06 Solazyme, Inc. Microalgal polysaccharide compositions
US8557249B2 (en) 2008-11-07 2013-10-15 Solazyme, Inc. Cosmetic compositions comprising microalgal components
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
AU2010313228B2 (en) * 2009-10-30 2014-05-29 Biogenic Innovations, Llc Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
US9855212B2 (en) 2009-10-30 2018-01-02 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
EP3936133A1 (de) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natürliche kombinationshormonersatzformulierungen und therapien
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471131B2 (en) 2012-01-19 2019-11-12 Hybrid Medical, Llc Topical therapeutic formulations
EP3269372B1 (de) 2012-01-19 2019-06-12 Hybrid Medical, LLC Topische therapeutische formulierungen
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof
EP2996672A4 (de) 2013-05-15 2016-11-02 Terravia Holdings Inc Kosmetische zusammensetzungen mit mikroalgenöl
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN105663018B (zh) 2014-12-03 2022-02-25 玫琳凯有限公司 化妆品组合物
US9572767B2 (en) 2015-05-20 2017-02-21 Jan Marini Skin Research Luminate hand cream
US10034825B2 (en) 2015-07-01 2018-07-31 Jan Marini Skin Research Luminate eye gel
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9687442B2 (en) 2015-07-27 2017-06-27 Mary Kay Inc. Topical skin formulations
EP3328354B1 (de) 2015-07-28 2023-06-28 Mary Kay, Inc. Topische hautformulierungen
US9949913B2 (en) 2016-03-14 2018-04-24 Jan Marini Skin Research Luminate face lotion
EP3435977A4 (de) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. Pharmazeutische steroidhormonzusammensetzung
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US10596090B2 (en) 2016-05-27 2020-03-24 Jan Marini Skin Research Cosmetic formulation to reduce facial flushing
US10610479B2 (en) 2017-08-07 2020-04-07 Jan Marini Skin Research HYLA3D hyaluronic acid activating lip complex
US10179103B1 (en) 2018-05-16 2019-01-15 Jan Marini Skin Research Anti-cellulite cream
EP4072513A1 (de) 2019-12-10 2022-10-19 Mary Kay, Inc. Pflanzliche kosmetische zusammensetzung zur behandlung der haut
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957734A (en) * 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5968989A (en) * 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US5853755A (en) 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use

Also Published As

Publication number Publication date
DE60110342T2 (de) 2006-01-26
EP1203579A1 (de) 2002-05-08
EP1203579B1 (de) 2005-04-27
DE60110342D1 (de) 2005-06-02
US6328987B1 (en) 2001-12-11
ATE293953T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE60110342T8 (de) Alpha-Interferon enthaltende Hautpflegemittel
ATE365534T1 (de) Kosmetische hautpflegezusammensetzungen
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
MX9201990A (es) Composiciones cosmeticas en forma de gel, transparentes, substancialmente anhidras y barras desodorantes y antitranspirantes que las contienen.
AU3227700A (en) Skin sanitizing compositions
ATE355104T1 (de) Haarbehandlungsmittel
AU3003199A (en) Tourmaline in cosmetic cleansing compositions
ES2149329T3 (es) Composiciones cosmeticas detergentes y utilizaciones.
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
ITMI20011022A0 (it) Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
FR2810540B1 (fr) Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
DE60309480D1 (de) Vitamin d-analoge
DE69831737D1 (de) Neurotrypsin
DE60209220D1 (de) Haarpflegemittel
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen
DE60230440D1 (de) Haarpflegeprodukte
DE60003074D1 (de) Fusidinsäure-derivate
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
MXPA05011953A (es) Composiciones cosmeticas para la piel.
ATE305041T1 (de) Kompositionen und verwendungen von cgi-69
ATE327727T1 (de) Hautpflegemittel
BR9611904A (pt) Dioxidos de ditiazol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition